Nautilus Biotechnology, Inc.NAUTNASDAQ
LOADING
|||
Operating Income Contraction
Below historical average, slight contraction.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-81.48M
↓ 39% below average
Average (6y)
$-58.47M
Historical baseline
Range
High:$-10.11M
Low:$-111.68M
CAGR
-5.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-81.48M | -7.0% |
| 2023 | $-76.15M | -19.7% |
| 2022 | $-63.62M | -26.0% |
| 2021 | $-50.50M | -220.7% |
| 2020 | $-15.74M | -55.7% |
| 2019 | $-10.11M | +90.9% |
| 2018 | $-111.68M | - |